Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study
- Resource Type
- Article
- Source
- In
Journal of the American Academy of Dermatology August 2023 89(2):235-242 - Subject
- Language
- ISSN
- 0190-9622